Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A O Ceballos-Baumann

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
MMW Fortschritte Der Medizin|June 20, 2002
[Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient]A O Ceballos-Baumann
Journal of Neurology|May 19, 2001
Evidence-based medicine in botulinum toxin therapy for cervical dystoniaA O Ceballos-Baumann
Der Internist|February 24, 2001
[Tremor--new therapy options]A O Ceballos-Baumann, H Boecker
Der Internist|May 28, 2017
A O Ceballos-Baumann, H Boecker
Advances in Neurology|January 1, 1997
Basal ganglia function and dysfunction revealed by PET activation studiesA O Ceballos-Baumann, D J Brooks
Advances in Neurology|September 29, 1998
Activation positron emission tomography scanning in dystoniaA O Ceballos-Baumann, D J Brooks
Muscle & Nerve|July 1, 1994
Botulinum toxin converts muscle acetylcholine receptors from adult to embryonic typeD Költgen, A O Ceballos-Baumann, C Franke
The New England Journal of Medicine|February 15, 2001
Botulinum toxin A for axillary hyperhidrosis (excessive sweating)M Heckmann, A O Ceballos-Baumann, G Plewig, et al.
MMW Fortschritte Der Medizin|March 9, 2002
[From neuromuscular blocker to analgesic. What is the value of botulinum toxin in pain therapy?]Th R Tölle, A O Ceballos-Baumann, A Straube
Der Nervenarzt|April 11, 2000
[Current perspectives of alexithymia]H Gündel, A O Ceballos-Baumann, M von Rad
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
MMW Fortschritte Der Medizin|June 20, 2002
[Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient]A O Ceballos-Baumann
Journal of Neurology|May 19, 2001
Evidence-based medicine in botulinum toxin therapy for cervical dystoniaA O Ceballos-Baumann
Der Internist|February 24, 2001
[Tremor--new therapy options]A O Ceballos-Baumann, H Boecker
Der Internist|May 28, 2017
A O Ceballos-Baumann, H Boecker
Advances in Neurology|January 1, 1997
Basal ganglia function and dysfunction revealed by PET activation studiesA O Ceballos-Baumann, D J Brooks
Advances in Neurology|September 29, 1998
Activation positron emission tomography scanning in dystoniaA O Ceballos-Baumann, D J Brooks
Muscle & Nerve|July 1, 1994
Botulinum toxin converts muscle acetylcholine receptors from adult to embryonic typeD Költgen, A O Ceballos-Baumann, C Franke
The New England Journal of Medicine|February 15, 2001
Botulinum toxin A for axillary hyperhidrosis (excessive sweating)M Heckmann, A O Ceballos-Baumann, G Plewig, et al.
MMW Fortschritte Der Medizin|March 9, 2002
[From neuromuscular blocker to analgesic. What is the value of botulinum toxin in pain therapy?]Th R Tölle, A O Ceballos-Baumann, A Straube
Der Nervenarzt|April 11, 2000
[Current perspectives of alexithymia]H Gündel, A O Ceballos-Baumann, M von Rad
Pageof 5